` EMV (EMvision Medical Devices Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

EMV
vs
S&P/ASX 300

Over the past 12 months, EMV has underperformed S&P/ASX 300, delivering a return of -16% compared to the S&P/ASX 300's 3% growth.

Stocks Performance
EMV vs S&P/ASX 300

Loading

Performance Gap
EMV vs S&P/ASX 300

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
EMV vs S&P/ASX 300

Loading
EMV
S&P/ASX 300
Add Stock

Competitors Performance
EMvision Medical Devices Ltd vs Peers

S&P/ASX 300
EMV
ABT
ISRG
BSX
SYK
Add Stock

EMvision Medical Devices Ltd
Glance View

Market Cap
158.6m AUD
Industry
Health Care

EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.

EMV Intrinsic Value
HIDDEN
Show
Back to Top